Literature DB >> 30279284

Ethanolamine Influences Human Commensal Escherichia coli Growth, Gene Expression, and Competition with Enterohemorrhagic E. coli O157:H7.

Carol A Rowley1, Christopher J Anderson1, Melissa M Kendall2.   

Abstract

A core principle of bacterial pathogenesis is that pathogens preferentially utilize metabolites that commensal bacteria do not in order to sidestep nutritional competition. The metabolite ethanolamine (EA) is well recognized to play a central role in host adaptation for diverse pathogens. EA promotes growth and influences virulence during host infection. Although genes encoding EA utilization have been identified in diverse bacteria (nonpathogenic and pathogenic), a prevailing idea is that commensal bacteria do not utilize EA to enhance growth, and thus, EA is a noncompetitive metabolite for pathogens. Here, we show that EA augments growth of two human commensal strains of Escherichia coli Significantly, these commensal strains grow more rapidly than, and even outcompete, the pathogen enterohemorrhagic E. coli O157:H7 specifically when EA is provided as the sole nitrogen source. Moreover, EA-dependent signaling is similarly conserved in the human commensal E. coli strain HS and influences expression of adhesins. These findings suggest a more extensive role for EA utilization in bacterial physiology and host-microbiota-pathogen interactions than previously appreciated.IMPORTANCE The microbiota protects the host from invading pathogens by limiting access to nutrients. In turn, bacterial pathogens selectively exploit metabolites not readily used by the microbiota to establish infection. Ethanolamine has been linked to pathogenesis of diverse pathogens by serving as a noncompetitive metabolite that enhances pathogen growth as well as a signal that modulates virulence. Although ethanolamine is abundant in the gastrointestinal tract, the prevailing idea is that commensal bacteria do not utilize EA, and thus, EA utilization has been particularly associated with pathogenesis. Here, we provide evidence that two human commensal Escherichia coli isolates readily utilize ethanolamine to enhance growth, modulate gene expression, and outgrow the pathogen enterohemorrhagic E. coli These data indicate a more complex role for ethanolamine in host-microbiota-pathogen interactions.
Copyright © 2018 Rowley et al.

Entities:  

Keywords:  ethanolamine; metabolism; microbiota; signaling

Mesh:

Substances:

Year:  2018        PMID: 30279284      PMCID: PMC6168858          DOI: 10.1128/mBio.01429-18

Source DB:  PubMed          Journal:  MBio            Impact factor:   7.867


OBSERVATION

The microbiota plays essential roles in human health. For example, the microbiota functions as a barrier against invading pathogens by limiting access to nutrients (1). Significantly, bacterial pathogens have evolved to exploit specific host- and microbiota-derived metabolites to sidestep nutritional competition and control expression of virulence traits (1). For instance, ethanolamine (EA) is abundant in the gastrointestinal (GI) tract due to the turnover of bacterial and epithelial cells (EA is a breakdown product of the cell membrane lipid phosphatidylethanolamine) as well as through the diet (2). EA utilization plays a central role in host adaptation for a diverse range of pathogens, including opportunistic pathogens (3, 4). EA can serve as a carbon, nitrogen, and/or energy source to promote growth as well as a signal to influence virulence during host infection (5–11). Genes encoding EA utilization are carried in the ethanolamine utilization (eut) locus (12). In the Enterobacteriaceae, the eut locus encodes the transcription factor EutR. EutR senses EA and vitamin B12 to directly activate eut transcription (13, 14). Moreover, in the foodborne pathogens enterohemorrhagic Escherichia coli O157:H7 (EHEC) and Salmonella enterica serovar Typhimurium, EutR regulates expression of virulence traits (5, 13, 15, 16). Despite the continual replenishment of EA in the GI tract, it has been reported that commensal bacteria do not utilize EA (17), and thus, EA utilization is a trait associated with pathogenesis (3, 4). The idea that EA is a noncompetitive metabolite for pathogens is largely perpetuated by data that showed that commensal E. coli isolated from ruminants did not consume EA in a modified bovine intestinal fluid (17). However, subsequent genome sequencing revealed that at least one of the E. coli strains used in the study contained several single nucleotide polymorphisms (SNPs) and an insertion element in the eut operon (18), which is expected to render this strain unable to utilize EA. In contrast, the eut operon of the human commensal E. coli HS strain contains an intact eut locus (19). HS was isolated from the stool of a healthy laboratory scientist and is used as a representative of nondomesticated E. coli in a number of human colonization studies (19–21). Therefore, to revisit EA utilization by human commensal E. coli, we assessed growth of HS when cultured in a minimal medium containing EA as the sole nitrogen or carbon source. Physiologically relevant concentrations of EA supported EutR-dependent growth of HS when provided as a nitrogen (but not carbon) source (Fig. 1A to C). Similarly to other E. coli strains, growth on EA required the addition of vitamin B12 (Fig. 1C).
FIG 1

EA-dependent growth and signaling in E. coli HS. (A) Growth curve of HS grown in minimal medium with indicated EA concentrations. n = 3. OD600, optical density at 600 nm. (B) Growth curve of wild type (WT) with empty vector, ΔeutR mutant with empty vector, and eutR complemented strain grown in minimal medium containing EA. n = 3. (C) Growth curve of HS grown in minimal medium with indicated carbon and nitrogen sources or without vitamin B12, as specifically indicated. n = 3. (D) Bacterial cell density at indicated time points after growth in minimal medium with NH4 or NH4 and EA. n = 3. (E) Reverse transcription-quantitative PCR (qRT-PCR) of eut gene expression in HS grown in in minimal medium with NH4 or NH4 and EA. n = 3. (F) qRT-PCR of fimbrial genes in HS grown in minimal medium with NH4 or NH4 and EA. n = 6. For all, unless indicated, vitamin B12 was added whenever the medium was supplemented with EA. Error bars represent the mean ± standard deviation (SD). **, P ≤ 0.01; ***, P < 0.001.

EA-dependent growth and signaling in E. coli HS. (A) Growth curve of HS grown in minimal medium with indicated EA concentrations. n = 3. OD600, optical density at 600 nm. (B) Growth curve of wild type (WT) with empty vector, ΔeutR mutant with empty vector, and eutR complemented strain grown in minimal medium containing EA. n = 3. (C) Growth curve of HS grown in minimal medium with indicated carbon and nitrogen sources or without vitamin B12, as specifically indicated. n = 3. (D) Bacterial cell density at indicated time points after growth in minimal medium with NH4 or NH4 and EA. n = 3. (E) Reverse transcription-quantitative PCR (qRT-PCR) of eut gene expression in HS grown in in minimal medium with NH4 or NH4 and EA. n = 3. (F) qRT-PCR of fimbrial genes in HS grown in minimal medium with NH4 or NH4 and EA. n = 6. For all, unless indicated, vitamin B12 was added whenever the medium was supplemented with EA. Error bars represent the mean ± standard deviation (SD). **, P ≤ 0.01; ***, P < 0.001. The GI tract contains several nitrogen sources that might diminish the potential importance of EA utilization in HS. To test this, we measured growth of HS in minimal medium containing NH4 only or NH4 and EA. When EA was added as a supplement to the medium, HS grew to a higher cell density than it did in medium containing only NH4 (Fig. 1D). In support of these data, we also measured a significant increase in eut gene expression from HS grown in medium supplemented with EA compared to medium without EA supplementation (minimal medium containing NH4 or Dulbecco’s modified Eagle’s medium) (Fig. 1E; see also Fig. S1 in the supplemental material). To confirm that EA utilization by a human E. coli isolate was not unique to the HS isolate, we next examined EA utilization in E. coli Nissle, which was isolated from the stool of a German soldier during World War I (22, 23). Consistent with the HS data, Nissle grew and responded to EA (Fig. S2A to D). Altogether, these data indicate that human commensal E. coli strains have maintained the ability to sense and utilize EA as a metabolite and that EA enhances growth in the presence of alternative nitrogen sources (as would be found in the gut). qRT-PCR of eut gene expression in E. coli HS grown in Dulbecco’s modified Eagle’s medium (DMEM) without or with EA and vitamin B12. n = 3; error bars represent the mean ± SD. **, P < 0.01. Download FIG S1, TIF file, 0.14 MB. EA-dependent growth and signaling in E. coli Nissle. (A) Growth curve of Nissle grown in minimal medium with indicated EA concentrations and vitamin B12. (B) Bacterial cell density at indicated time points after growth in minimal medium with NH4 or with NH4, EA, and vitamin B12. (C) qRT-PCR of eut gene expression in HS grown in DMEM without or with EA and vitamin B12. (D) qRT-PCR of eut gene expression in Nissle grown in minimal medium containing NH4 or EA and vitamin B12. For all, n equals 3; error bars represent the mean ± SD. *, P < 0.05; **, P ≤ 0.01; ***, P ≤ 0.001. Download FIG S2, TIF file, 0.31 MB. We previously reported that EA influences expression of genes carried outside the eut locus in EHEC and Salmonella, including expression of fimbriae (5, 13, 15, 16). HS and EHEC share a conserved set of fimbrial loci; therefore, we next measured expression of one gene in each of the conserved loci (expression of eight genes was measured) in HS grown in minimal medium with NH4 only or NH4 and EA. We measured an ∼2- and 3-fold change in expression of genes carried in the yad and ybg loci, respectively (Fig. 1F). Interestingly, EA supplementation resulted in reduced levels of fimbrial gene expression in HS, which is the opposite of the impact of EA on EHEC fimbrial gene expression. These differences in expression may be reflective of the different colonization niches of these strains (lumen/mucus [HS] versus epithelial attachment [EHEC]). Regardless, these findings provide proof-of-principle data that similarly to EA-dependent growth, EA-dependent signaling is conserved in human commensal E. coli and not restricted to pathogens. Scavenging nutrients is paramount for success in colonizing the host intestinal niche (24, 25). Commensal E. coli and EHEC compete for similar resources (24), and EA has been proposed to provide a selective growth advantage to EHEC over commensal E. coli (17). Therefore, we next compared growth of HS and EHEC in EA-minimal medium (containing glucose as the carbon source). Surprisingly, HS grew more rapidly than EHEC when EA was provided as the sole nitrogen source (Fig. 2A), with a doubling time of 1.6 h compared to 4.3 h, respectively (of note, the doubling time of Nissle was 1.3 h [Fig. S2A]). Consistent with these data, during competition HS was recovered at nearly 10-fold-higher levels than EHEC (Fig. 2B). eut expression and/or enzymatic activity may be subject to carbon catabolite repression (26, 27); therefore, it is possible that effectiveness of carbon catabolite repression between HS and EHEC caused the differences in growth rates. To test this idea, we repeated the growth and competition experiments in EA-minimal medium containing glycerol as the sole carbon source. During exponential growth, growth rates of HS and EHEC were similar to growth rates in medium containing glucose, with doubling times of 1.4 h and 4.2 h, respectively (Fig. 2C). Of note, we observed a slightly shorter lag phase for EHEC grown in EA-minimal medium containing glycerol compared to glucose. Even so, consistent with the previous assay, HS was recovered in higher numbers than EHEC during competition (>2-fold) (Fig. 2D). Interestingly, this growth advantage was specific for EA utilization as no differences in bacterial growth or recovery were measured when HS and EHEC were cultured in minimal medium containing NH4 as the sole nitrogen source (Fig. 2E and F and Fig. S3A and B).
FIG 2

HS outcompetes EHEC specifically during growth on EA. (A) Growth curve of E. coli HS and EHEC in minimal medium with EA and glucose. (B) Competition assay between E. coli HS and EHEC in minimal medium with EA and glucose. (C) Growth curve of E. coli HS and EHEC in minimal medium with EA and glycerol. (D) Competition assay between E. coli HS and EHEC in minimal medium with EA and glycerol. For panels A to D, vitamin B12 was added to the medium. (E) Growth curve of E. coli HS and EHEC in minimal medium with NH4 and glucose. (F) Competition assay between E. coli HS and EHEC in minimal medium with NH4 and glucose. For all, n equals 3; error bars represent the mean ± standard deviation. *, P ≤ 0.05; **, P ≤ 0.01; ns, P > 0.05.

HS outcompetes EHEC specifically during growth on EA. (A) Growth curve of E. coli HS and EHEC in minimal medium with EA and glucose. (B) Competition assay between E. coli HS and EHEC in minimal medium with EA and glucose. (C) Growth curve of E. coli HS and EHEC in minimal medium with EA and glycerol. (D) Competition assay between E. coli HS and EHEC in minimal medium with EA and glycerol. For panels A to D, vitamin B12 was added to the medium. (E) Growth curve of E. coli HS and EHEC in minimal medium with NH4 and glucose. (F) Competition assay between E. coli HS and EHEC in minimal medium with NH4 and glucose. For all, n equals 3; error bars represent the mean ± standard deviation. *, P ≤ 0.05; **, P ≤ 0.01; ns, P > 0.05. (A) Growth curve of E. coli HS and EHEC in minimal medium with NH4 and glycerol. (B) Competition assay between E. coli HS and EHEC in minimal medium with NH4 and glycerol. For all, n equals 3; error bars represent the mean ± SD. ns, P > 0.05. Download FIG S3, TIF file, 0.11 MB. Although genes encoding EA utilization are carried by phylogenetically diverse bacteria (27), EA utilization has been suggested to be a potential virulence determinant and/or has been specifically linked to pathogenesis (i.e., references 4, 7, and 28 to 31). Our findings reveal that commensal GI bacteria rely on EA to enhance growth, and thus, EA utilization and signaling are more complex than previously appreciated. This work suggests that further investigation on the impact of EA utilization on host-microbiota-pathogen interaction is warranted. Supplemental materials and methods. Download Text S1, PDF file, 0.05 MB. Oligonucleotides used in this study. Download Table S1, PDF file, 0.02 MB.
  29 in total

1.  EutR is a direct regulator of genes that contribute to metabolism and virulence in enterohemorrhagic Escherichia coli O157:H7.

Authors:  Deborah H Luzader; David E Clark; Laura A Gonyar; Melissa M Kendall
Journal:  J Bacteriol       Date:  2013-08-30       Impact factor: 3.490

2.  Riboswitches. Sequestration of a two-component response regulator by a riboswitch-regulated noncoding RNA.

Authors:  J R Mellin; Mikael Koutero; Daniel Dar; Marie-Anne Nahori; Rotem Sorek; Pascale Cossart
Journal:  Science       Date:  2014-08-22       Impact factor: 47.728

3.  Role of Ethanolamine Utilization Genes in Host Colonization during Urinary Tract Infection.

Authors:  Anna Sintsova; Sara Smith; Sargurunathan Subashchandrabose; Harry L Mobley
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

4.  Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota.

Authors:  Parameth Thiennimitr; Sebastian E Winter; Maria G Winter; Mariana N Xavier; Vladimir Tolstikov; Douglas L Huseby; Torsten Sterzenbach; Renée M Tsolis; John R Roth; Andreas J Bäumler
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

5.  The Ethanolamine Permease EutH Promotes Vacuole Adaptation of Salmonella enterica and Listeria monocytogenes during Macrophage Infection.

Authors:  Christopher J Anderson; John Satkovich; Volkan K Köseoğlu; Hervé Agaisse; Melissa M Kendall
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

Review 6.  Ethanolamine utilization in bacterial pathogens: roles and regulation.

Authors:  Danielle A Garsin
Journal:  Nat Rev Microbiol       Date:  2010-04       Impact factor: 60.633

7.  Ethanolamine utilization in Salmonella typhimurium.

Authors:  D M Roof; J R Roth
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

8.  Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin.

Authors:  M M Levine; E S Caplan; D Waterman; R A Cash; R B Hornick; M J Snyder
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

9.  Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive.

Authors:  M M Levine; E J Bergquist; D R Nalin; D H Waterman; R B Hornick; C R Young; S Sotman
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

10.  Ethanolamine is a valuable nutrient source that impacts Clostridium difficile pathogenesis.

Authors:  Kathryn L Nawrocki; Daniela Wetzel; Joshua B Jones; Emily C Woods; Shonna M McBride
Journal:  Environ Microbiol       Date:  2018-02-09       Impact factor: 5.491

View more
  11 in total

Review 1.  Taming the Beast: Interplay between Gut Small Molecules and Enteric Pathogens.

Authors:  Aman Kumar; Melissa Ellermann; Vanessa Sperandio
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

2.  The Ethanolamine-Sensing Transcription Factor EutR Promotes Virulence and Transmission during Citrobacter rodentium Intestinal Infection.

Authors:  Carol A Rowley; Amber B Sauder; Melissa M Kendall
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

Review 3.  Escherichia coli 0157:H7 virulence factors and the ruminant reservoir.

Authors:  Anna M Kolodziejek; Scott A Minnich; Carolyn J Hovde
Journal:  Curr Opin Infect Dis       Date:  2022-06-01       Impact factor: 4.968

4.  Microbes exploit death-induced nutrient release by gut epithelial cells.

Authors:  Christopher B Medina; Brady J Barron; Christopher J Anderson; Laura Karvelyte; Tania Løve Aaes; Irina Lambertz; Justin S A Perry; Parul Mehrotra; Amanda Gonçalves; Kelly Lemeire; Gillian Blancke; Vanessa Andries; Farzaneh Ghazavi; Arne Martens; Geert van Loo; Lars Vereecke; Peter Vandenabeele; Kodi S Ravichandran
Journal:  Nature       Date:  2021-08-04       Impact factor: 49.962

5.  Mucosal metabolites fuel the growth and virulence of E. coli linked to Crohn's disease.

Authors:  Shiying Zhang; Xochitl Morgan; Belgin Dogan; Francois-Pierre Martin; Suzy Strickler; Akihiko Oka; Jeremy Herzog; Bo Liu; Scot E Dowd; Curtis Huttenhower; Matthieu Pichaud; Esra I Dogan; Jack Satsangi; Randy Longman; Rhonda Yantiss; Lukas A Mueller; Ellen J Scherl; R Balfour Sartor; Kenneth W Simpson
Journal:  JCI Insight       Date:  2022-05-23

6.  Complex Bacterial Consortia Reprogram the Colitogenic Activity of Enterococcus faecalis in a Gnotobiotic Mouse Model of Chronic, Immune-Mediated Colitis.

Authors:  Isabella Lengfelder; Irina G Sava; Jonathan J Hansen; Karin Kleigrewe; Jeremy Herzog; Klaus Neuhaus; Thomas Hofmann; R Balfour Sartor; Dirk Haller
Journal:  Front Immunol       Date:  2019-06-20       Impact factor: 7.561

7.  The Immune Protein Calprotectin Impacts Clostridioides difficile Metabolism through Zinc Limitation.

Authors:  Christopher A Lopez; William N Beavers; Andy Weiss; Reece J Knippel; Joseph P Zackular; Walter Chazin; Eric P Skaar
Journal:  mBio       Date:  2019-11-19       Impact factor: 7.867

8.  A Novel Small RNA Promotes Motility and Virulence of Enterohemorrhagic Escherichia coli O157:H7 in Response to Ammonium.

Authors:  Tianyuan Jia; Bin Liu; Huiqian Mu; Chengqian Qian; Lu Wang; Linxing Li; Gege Lu; Wenxuan Zhu; Xi Guo; Bin Yang; Di Huang; Lu Feng; Bin Liu
Journal:  mBio       Date:  2021-03-09       Impact factor: 7.867

9.  Streptozotocin-induced hyperglycemia alters the cecal metabolome and exacerbates antibiotic-induced dysbiosis.

Authors:  Jenna I Wurster; Rachel L Peterson; Claire E Brown; Swathi Penumutchu; Douglas V Guzior; Kerri Neugebauer; William H Sano; Manu M Sebastian; Robert A Quinn; Peter Belenky
Journal:  Cell Rep       Date:  2021-12-14       Impact factor: 9.423

10.  Synthesis of Escherichia coli OmpA Oral Nanoparticles and Evaluation of Immune Functions against the Major Etiologic Agent of Cow Mastitis.

Authors:  Xiang Liu; Wei Sun; Nana Wu; Na Rong; Chao Kang; Sijie Jian; Chunlin Chen; Chen Chen; Xiaoying Zhang
Journal:  Vaccines (Basel)       Date:  2021-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.